HOUSTON--(BUSINESS WIRE)--Black Beret Life Sciences LLC has finalized the acquisition of Okyanos Operating Company, Ltd., a state-of-the-art adult stem cell and regenerative medicine center based in Freeport, Grand Bahama.
Dr. W.E. (“Ed”) Bosarge founded Black Beret Life Sciences (BBLS) to identify and manage investments in game-changing biotechnology innovations on behalf of the Bosarge family office and other investors. Since its launch in 2014, BBLS has invested in and supported key research and development efforts in regenerative medicine, obesity and diabetes, and cancer therapeutics.
Marc S. Penn, MD, PhD, FACC, serves as CEO and Chief Medical and Science Officer at BBLS, leading teams of researchers specializing in diverse medical disciplines. “BBLS invests in and helps manage companies which could dramatically improve patient outcomes for chronic conditions. The Okyanos Center for Regenerative Medicine provides adult stem cell therapy in a regulated jurisdiction with the highest level of safety and care,” said Dr. Penn. “We look forward to the continued growth of Okyanos in collaboration with the National Stem Cell Ethics Committee of the Bahamas. Our goal is to develop an international stem cell treatment network that is deeply rooted in patient safety, the best medical practices and transparency. We will rigorously follow-up on our patient’s treatment utilizing clinically meaningful measures to build a database of knowledge to accelerate the development of the regenerative medicine field globally.”
Founded in 2011, Okyanos is located in Freeport, Grand Bahama, just 30 minutes from southern Florida. Okyanos is licensed by the Bahamas’ National Stem Cell Ethics Committee (NSCEC), providing safe, regenerative therapies to patients with chronic conditions so they can live longer and healthier lives.
ABOUT BLACK BERET LIFE SCIENCES
Black Beret Life Sciences (BBLS) is the investment and management arm of the Houston-based Bosarge Family Office. The firm was established in 2014 by Dr. Ed Bosarge to organize and manage investments in potentially game-changing bio-technology and healthcare companies focused on regenerative medicine, anti-aging and immunotherapy. With an overall goal of extending healthier life, BBLS’ portfolio of managed investments includes companies and research across an array of disease spectrums, including diabetes, neurodegeneration, osteoarthritis, cancer immunotherapy and various conditions related to aging. BBLS is based in Houston, TX, with offices worldwide. Learn more at https://www.bbls.net.
ABOUT OKYANOS CENTER FOR REGENERATIVE MEDICINE (OH – KEY – AH – NOS)
A state-of-the art regenerative medicine center delivering cutting edge therapies for chronic conditions, Okyanos is a leading adult stem cell therapy provider with world class physicians and staff. Okyanos helps people with chronic, degenerative diseases including orthopedic, cardiac, neurologic and urologic conditions return to a more normal life through a treatment approach using fat-derived stem cells. Based in Freeport, Grand Bahama, Okyanos is licensed under the Bahamas Stem Cell Therapy and Research Act. The literary name Okyanos, the Greek god of the river Okeanos, symbolizes restoration of blood flow. Learn more at www.okyanos.com.